Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 83.36% | 54.53% | 196.74% | -27.46% | -1,435.64% |
| Total Depreciation and Amortization | -17.20% | -20.83% | -56.28% | -64.12% | -8.44% |
| Total Amortization of Deferred Charges | -1.85% | -1.85% | -1.85% | -1.85% | -1.82% |
| Total Other Non-Cash Items | -98.25% | -102.36% | -38.88% | 6.55% | 759.24% |
| Change in Net Operating Assets | -22.60% | 74.46% | -24.54% | -1,829.77% | 74.67% |
| Cash from Operations | -35.50% | 25.48% | -10.84% | -121.71% | 37.64% |
| Capital Expenditure | 99.52% | 94.36% | -20.21% | -21.86% | -6,959.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -315.19% | -403.57% | -753.36% | 114.12% | -1,394.66% |
| Cash from Investing | 43.70% | 80.34% | -74.90% | 71.63% | -203.45% |
| Total Debt Issued | -- | -100.00% | -- | -- | -100.00% |
| Total Debt Repaid | 51.15% | -5,154.15% | 20.63% | 54.55% | 71.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -115.79% | -125.62% | 29.93% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 437.78% | -- | 100.00% |
| Cash from Financing | 56.01% | -326.08% | 281.42% | 169.75% | 72.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 304.33% | 49.67% | 189.16% | 51.95% | 85.43% |
